HCM HUTCHMED (China) Limited - American Depositary Shares
NASDAQ · Pharmaceuticals · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 三月 5, 2026
$14.20
· % 处于52周区间
· 高于低点
· 至高点
$9.7752周低点
$16.4052周高点
市值
$12.39B
P/E
27.3
EPS
$0.52
收入
$549M
HCM 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$14.20
市值
$12.39B
P/E
27.3
EPS
$0.52
收入
$549M
ROE
45.7%
负债/权益
0.1
52周区间
$10–$16
HCM 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
10年表现 收入、净利润、利润率和每股收益趋势
收入$549M2016-12-31 → 2025-12-31
EPS$0.522016-12-31 → 2025-12-31
自由现金流$-79M2016-12-31 → 2025-12-31
净利率83.3%2016-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | HCM | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E | 27.35年均值 ≈72.4 | ≈72.4 | · | · | |
| P/S | 22.65年均值 ≈35.0 | ≈35.0 | · | · | |
| P/B (市净率) | 10.05年均值 ≈19.8 | ≈19.8 | · | · | |
| EV / EBITDA (企业价值 / EBITDA) | -430.85年均值 ≈-67.2 | ≈-67.2 | · | · | |
| Price / FCF (股价/自由现金流) | -157.25年均值 ≈-192.5 | ≈-192.5 | · | · | |
| Price / Cash Flow (市现率) | -191.65年均值 ≈4993.4 | ≈4993.4 | · | · | |
| EV / Revenue (市值/营收) | 20.35年均值 ≈33.3 | ≈33.3 | · | · | |
| EV / FCF (市值/自由现金流) | -141.35年均值 ≈-180.5 | ≈-180.5 | · | · | |
| Price / Tangible Book (市净率（有形资产）) | 10.15年均值 ≈19.9 | ≈19.9 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | HCM | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Operating Margin (营业利润率) | -7.1%5年均值 ≈-39.9% | ≈-39.9% | · | · | |
| EBITDA Margin (息税折旧摊销前利润率) | -4.7%5年均值 ≈-38.1% | ≈-38.1% | · | · | |
| Pretax Margin (税前利润率) | 90.9%5年均值 ≈-11.8% | ≈-11.8% | · | · | |
| Net Profit Margin (净利润率) | 83.3%5年均值 ≈-7.6% | ≈-7.6% | · | · | |
| ROA | 30.2%5年均值 ≈-1.3% | ≈-1.3% | · | · | |
| ROE | 45.7%5年均值 ≈-1.2% | ≈-1.2% | · | · | |
| ROIC | -2.5%5年均值 ≈-27.5% | ≈-27.5% | · | · |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | HCM | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Debt / Equity (负债/股东权益比率) | 0.15年均值 ≈0.1 | ≈0.1 | · | · | |
| Current Ratio (流动比率) | 5.05年均值 ≈3.4 | ≈3.4 | · | · | |
| Quick Ratio (速动比率) | 4.75年均值 ≈3.1 | ≈3.1 | · | · | |
| Long-Term Debt / Equity (长期负债/股东权益) | 0.15年均值 ≈0.1 | ≈0.1 | · | · |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
此比率组尚无数据
基本面数据不足，尚无法计算此比率组。
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | HCM | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.45年均值 ≈0.5 | ≈0.5 | · | · | |
| Inventory Turnover (库存周转率) | 7.3 | · | · | · | |
| Receivables Turnover (应收账款周转率) | 3.95年均值 ≈5.3 | ≈5.3 | · | · | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$306.4K | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
95.6%
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2023年6月30日 | $0.19 | $-0.38 | 149.9% | |
| 2021年12月31日 | $-0.26 | $-1.06 | 75.6% | |
| 2021年6月30日 | $-0.14 | $-0.77 | 81.9% | |
| 2020年12月31日 | $-0.11 | $-0.44 | 75.2% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $549M | $630M | $838M | $426M | $356M | $228M | $205M | $214M | $241M | $216M | $178M | $87M | |
| Cost of Revenue | $336M | $349M | $384M | $311M | · | · | · | · | $170M | $149M | $105M | $53M | |
| R&D Expense | $148M | $212M | $302M | $387M | $299M | $175M | $138M | $114M | $76M | $67M | $47M | $30M | |
| SG&A Expense | $67M | $64M | $80M | $92M | $89M | $50M | $39M | $31M | $24M | $22M | $20M | $13M | |
| Operating Expenses | $588M | $674M | $820M | $834M | $684M | $425M | $351M | $307M | $295M | $263M | $188M | $106M | |
| Operating Income | $-39M | $-44M | $18M | $-408M | $-328M | $-197M | $-146M | $-93M | $-53M | $-47M | $-10M | $-18M | |
| Interest Expense | · | · | $759.0K | $652.0K | $592.0K | $787.0K | $1M | $1M | $1M | $2M | $1M | $2M | |
| Interest Income | $50M | $40M | $36M | $10M | $2M | $3M | $5M | $6M | $1M | $502.0K | $451.0K | $559.0K | |
| Other Non-op | $61M | $43M | $40M | $-3M | $-9M | $7M | $5M | $6M | $-119.0K | $-659.0K | $-769.0K | $-761.0K | |
| Pretax Income | $499M | $-1M | $58M | $-410M | $-216M | $-190M | $-141M | $-87M | $-54M | $-47M | $-11M | $-3M | |
| Income Tax | $64M | $7M | $5M | $-283.0K | $12M | $5M | $3M | $4M | $3M | $4M | $2M | $1M | |
| Net Income | $457M | $38M | $101M | $-361M | $-195M | $-126M | $-106M | $-75M | $-27M | $12M | $8M | $-7M | |
| EPS (Basic) | $0.53 | $0.04 | $0.12 | $-0.43 | $-0.25 | $-0.18 | $-0.16 | $-0.11 | $-0.04 | $0.20 | $-0.64 | $-0.62 | |
| EPS (Diluted) | $0.52 | $0.04 | $0.12 | $-0.43 | $-0.25 | $-0.18 | $-0.16 | $-1.13 | $-0.43 | $0.20 | $-0.64 | $-0.62 | |
| Shares (Basic) | 858,276,608 | 855,351,683 | 849,654,296 | 847,143,540 | 792,684,524 | 697,931,437 | 665,683,145 | 664,263,820 | 617,171,710 | 59,715,173 | 54,659,315 | 52,563,387 | |
| Shares (Diluted) | 872,891,120 | 872,829,129 | 869,196,348 | 847,143,540 | 792,684,524 | 697,931,437 | 665,683,145 | 66,426,382 | 61,717,171 | 59,971,050 | 54,659,315 | 52,563,387 | |
| EBITDA | $-26M | $-31M | $27M | $-399M | $-321M | $-191M | $-141M | $-89M | $-51M | $-44M | · | · |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $71M | $154M | $284M | $313M | $378M | $236M | $121M | $86M | $85M | $79M | $32M | $39M | |
| Short-term Investments | $1.30B | $682M | $603M | $318M | $634M | $200M | $96M | $215M | $273M | $24M | $0 | · | |
| Receivables | $127M | $156M | $117M | $98M | $84M | $48M | $41M | $40M | $38M | $41M | $33M | · | |
| Inventory | $41M | $50M | $50M | $57M | $36M | $20M | $16M | $12M | $12M | $13M | $10M | · | |
| Prepaid Expense | $8M | $8M | $7M | $22M | $14M | $7M | $4M | $4M | $3M | $699.0K | · | · | |
| Current Assets | $1.57B | $1.07B | $1.10B | $840M | $1.21B | $531M | $317M | $371M | $432M | $167M | $90M | · | |
| PP&E (Net) | $95M | $92M | $100M | $76M | $41M | $24M | $21M | $17M | $14M | $10M | $9M | · | |
| PP&E (Gross) | $168M | $152M | $146M | $113M | $74M | $50M | $44M | $36M | $32M | $24M | $22M | · | |
| Accum. Depreciation | · | · | · | $37M | $33M | $26M | $23M | $20M | $17M | $14M | $13M | $13M | |
| Goodwill | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Intangibles | $9M | · | $21.0K | $85.0K | $163.0K | $227.0K | $275.0K | $347.0K | $430.0K | $469.0K | $571.0K | · | |
| Other Non-current Assets | $20M | $12M | $15M | $16M | $22M | $20M | $6M | · | · | · | · | · | |
| Total Assets | $1.75B | $1.27B | $1.28B | $1.03B | $1.37B | $724M | $465M | $532M | $598M | $342M | $230M | · | |
| Accounts Payable | $46M | $43M | $36M | $71M | $41M | $32M | $24M | $26M | $24M | $36M | $21M | · | |
| Short-term Debt | $25M | $23M | $31M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $316M | $377M | $403M | $354M | $312M | $158M | $113M | $85M | $105M | $95M | $81M | · | |
| Capital Leases | $2M | $4M | $3M | $5M | $7M | $6M | $3M | · | · | · | · | · | |
| Deferred Tax | $255.0K | $3M | $1M | $3M | $3M | $5M | $3M | · | $4M | $4M | $3M | · | |
| Other Non-current Liabilities | · | $11M | $11M | $12M | $12M | $9M | $6M | $2M | $1M | $8M | $10M | · | |
| Total Liabilities | $502M | $502M | $536M | $393M | $333M | $205M | $152M | $120M | $113M | $138M | $127M | · | |
| Long-term Debt | $93M | $83M | $79M | $18M | · | · | · | $27M | $30M | $47M | $50M | · | |
| Total Debt | $118M | $106M | $110M | $18M | $27M | $27M | $27M | $27M | $30M | $27M | · | · | |
| Common Stock | $87M | $87M | $87M | $86M | $86M | $73M | $67M | $67M | $66M | $61M | $57M | · | |
| Retained Earnings | $-379M | $-833M | $-871M | $-971M | $-610M | $-416M | $-290M | $-183M | $-107M | $-80M | $-92M | · | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | $2M | $2M | · | |
| AOCI | $-5M | $-12M | $-8M | $-2M | $6M | $4M | $-4M | $-243.0K | $5M | $-4M | $5M | · | |
| Stockholders' Equity | $1.24B | $760M | $731M | $610M | $987M | $484M | $288M | $389M | $462M | $184M | $83M | · | |
| Liabilities + Equity | $1.75B | $1.27B | $1.28B | $1.03B | $1.37B | $724M | $465M | $532M | $598M | $342M | $230M | · | |
| Shares Outstanding | 872,328,000 | 871,601,000 | 871,256,000 | 864,775,000 | 864,531,000 | 727,722,000 | 666,906,000 | 666,577,000 | 664,470,000 | 607,058,000 | 56,533,000 | 53,076,000 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $13M | $12M | $8M | $9M | $7M | $6M | $5M | $4M | $3M | $2M | $2M | $1M | |
| Deferred Tax | $-118.0K | $5M | $2M | $-4M | $-5M | $3M | $2M | $2M | $2M | $3M | $1M | · | |
| Other Non-cash | $-596M | $-117M | $179M | $146M | $20M | $84M | $35M | $44M | $-1M | $-24M | · | · | |
| Operating Cash Flow | $-65M | $497.0K | $219M | $-269M | $-204M | $-62M | $-81M | $-33M | $-9M | $-10M | $-9M | $8M | |
| CapEx | $14M | $18M | $33M | $37M | $16M | $8M | $9M | $6M | $5M | $4M | $3M | $4M | |
| Investing Cash Flow | $-29M | $-96M | $-291M | $297M | $-306M | $-125M | $119M | $44M | $-261M | $-34M | $9M | $-15M | |
| Stock Issued | $2M | $790.0K | $5M | $174.0K | $717M | $319M | $251.0K | $4M | $302M | $111M | $1M | $3M | |
| Stock Repurchased | · | $36M | $9M | $48M | $27M | $13M | $346.0K | $5M | $1M | $604.0K | $2M | · | |
| Net Stock Activity | $2M | $-35M | $-4M | $-48M | $690M | $306M | $-95.0K | $-2M | $300M | $110M | · | · | |
| Financing Cash Flow | $8M | $-31M | $49M | $-83M | $650M | $296M | $-1M | $-8M | $273M | $92M | $-5M | $-641.0K | |
| Net Change in Cash | $-83M | $-130M | $-30M | $-64M | $142M | $114M | $35M | $771.0K | $6M | $47M | $-7M | $-8M | |
| Taxes Paid | $62M | $4M | $4M | $19M | $5M | $6M | $3M | $4M | $4M | $3M | $510.0K | $-908.0K | |
| Free Cash Flow | $-79M | $-17M | $187M | $-305M | $-221M | $-70M | $-89M | $-39M | $-14M | $-14M | · | · | |
| Levered FCF | · | · | $186M | $-306M | $-221M | $-71M | $-91M | $-40M | $-16M | $-15M | · | · |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -7.1% | -6.9% | 2.2% | -95.6% | -92.2% | -86.3% | -71.5% | -43.3% | -22.1% | -21.6% | · | · | |
| Net Margin | 83.3% | 6.0% | 12.0% | -84.6% | -54.7% | -55.1% | -51.7% | -34.9% | -11.1% | 5.4% | · | · | |
| Pretax Margin | 90.9% | -0.18% | 7.0% | -96.2% | -60.6% | -83.2% | -68.9% | -40.5% | -22.2% | 9.5% | · | · | |
| EBITDA Margin | -4.7% | -5.0% | 3.2% | -93.6% | -90.2% | -83.6% | -69.0% | -41.6% | -21.1% | -20.5% | · | · | |
| ROA | 30.2% | 2.9% | 8.7% | -30.0% | -18.6% | -21.1% | -21.3% | -13.2% | -5.7% | 4.1% | · | · | |
| ROE | 45.7% | 5.1% | 15.0% | -45.2% | -26.5% | -32.6% | -31.3% | -17.6% | -8.3% | 8.7% | · | · | |
| ROIC | -2.5% | -37.8% | 2.0% | -64.8% | -34.2% | -39.5% | -47.6% | -23.3% | -11.5% | -17.4% | · | · |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 2.8 | 2.7 | 2.4 | 3.9 | 3.4 | 2.8 | 4.3 | 4.1 | 1.8 | · | · | |
| Quick Ratio | 4.7 | 2.6 | 2.5 | 2.1 | 3.5 | 3.0 | 2.3 | 4.0 | 3.8 | 1.5 | · | · | |
| Debt / Equity | 0.1 | 0.1 | 0.2 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | · | · | |
| LT Debt / Equity | 0.1 | 0.1 | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | · | · | |
| Interest Coverage | · | · | 24.2 | -625.3 | -554.6 | -249.9 | -142.1 | -91.8 | -36.7 | -28.6 | · | · |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.5 | 0.7 | 0.4 | 0.3 | 0.4 | 0.4 | 0.4 | 0.5 | 0.8 | · | · | |
| Inventory Turnover | 7.3 | 6.9 | · | · | · | · | · | · | 13.8 | 13.3 | · | · | |
| Receivables Turnover | 3.9 | 4.6 | 7.8 | 4.7 | 5.4 | 5.2 | 5.0 | 5.4 | 6.1 | 5.8 | · | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.42 | $0.87 | $0.84 | $0.71 | $1.14 | $0.67 | $0.43 | $5.84 | $6.95 | $3.04 | · | · | |
| Revenue / Share | $0.63 | $0.72 | $0.96 | $0.50 | $0.45 | · | · | $3.22 | $3.91 | $3.60 | · | · | |
| Cash Flow / Share | $-0.07 | $0.00 | $0.25 | $-0.32 | $-0.26 | · | · | $-0.49 | $-0.14 | $-0.16 | · | · | |
| Cash / Share | $0.08 | $0.18 | $0.33 | $0.36 | $0.44 | $0.32 | $0.18 | $1.29 | $1.28 | $1.31 | · | · | |
| EPS (TTM) | $0.52 | $0.04 | $0.12 | $-0.43 | $-0.25 | $-0.18 | $-0.16 | $-1.13 | $-0.43 | $0.20 | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $549M | $630M | $838M | $426M | $356M | $228M | $205M | $214M | $241M | $216M | · | · | |
| Net Income TTM | $457M | $38M | $101M | $-361M | $-195M | $-126M | $-106M | $-75M | $-27M | $12M | · | · | |
| Market Cap | $11.63B | $12.56B | $15.78B | $12.78B | $30.33B | $23.30B | $16.72B | $1.54B | $2.62B | $824M | · | · | |
| Enterprise Value | $10.38B | $11.83B | $15.00B | $12.17B | $29.34B | $22.89B | $16.53B | $1.26B | $2.29B | $747M | · | · | |
| P/E | 25.6 | 360.2 | 150.9 | -34.4 | -140.3 | -177.9 | -156.7 | -20.4 | -91.7 | 67.8 | · | · | |
| P/S | 21.2 | 19.9 | 18.8 | 30.0 | 85.2 | 102.2 | 81.6 | 7.2 | 10.9 | 3.8 | · | · | |
| P/B | 9.4 | 16.5 | 21.6 | 20.9 | 30.7 | 48.1 | 58.1 | 4.0 | 5.7 | 4.5 | · | · | |
| P / Tangible Book | 9.5 | 16.6 | 21.7 | 21.1 | 30.8 | 48.5 | · | · | · | · | · | · | |
| P / Cash Flow | -179.8 | 25271.2 | 72.0 | -47.6 | -148.5 | -375.4 | -206.6 | -46.9 | -292.9 | -86.1 | · | · | |
| P / FCF | -147.6 | -720.3 | 84.5 | -41.9 | -137.5 | -332.8 | -186.9 | -39.3 | -187.6 | -59.3 | · | · | |
| EV / EBITDA | -401.5 | -377.2 | 564.4 | -30.5 | -91.4 | -120.1 | -116.9 | -14.2 | -45.1 | -16.8 | · | · | |
| EV / FCF | -131.7 | -678.5 | 80.4 | -39.9 | -133.0 | -327.0 | -184.7 | -32.3 | -164.1 | -53.8 | · | · | |
| EV / Revenue | 18.9 | 18.8 | 17.9 | 28.5 | 82.4 | 100.4 | 80.7 | 5.9 | 9.5 | 3.5 | · | · | |
| Earnings Yield | 3.9% | 0.28% | 0.66% | -2.9% | -0.71% | -0.56% | -0.64% | -4.9% | -1.1% | 1.5% | · | · |
每股
| 指标 | 趋势 | Q4 2019 | Q4 2018 |
|---|---|---|---|
| EPS (TTM) | $-0.16 | $-1.13 |
估值 (TTM)
| 指标 | 趋势 | Q4 2019 | Q4 2018 |
|---|---|---|---|
| Revenue TTM | $205M | $214M | |
| Net Income TTM | $-106M | $-75M | |
| P/E | -156.7 | -20.4 | |
| Earnings Yield | -0.64% | -4.9% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $549M | $630M | $838M | $426M | $356M |
| 营业利润率 % | -7.1% | -6.9% | 2.2% | -95.6% | -92.2% |
| 净收入 | $457M | $38M | $101M | $-361M | $-195M |
| 稀释后每股收益 (EPS) | $0.52 | $0.04 | $0.12 | $-0.43 | $-0.25 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 负债/股东权益比率 | 0.1 | 0.1 | 0.2 | 0.0 | 0.0 |
| 流动比率 | 5.0 | 2.8 | 2.7 | 2.4 | 3.9 |
| 速动比率 | 4.7 | 2.6 | 2.5 | 2.1 | 3.5 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $-79M | $-17M | $187M | $-305M | $-221M |
机构持有人 (13F) 58 家申报者 · $45.7M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
58
持有价值
$45.7M
新仓位
9
已退出持仓
4
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 9 (+1 与上一季度对比) | 4 (-1 与上一季度对比) | 14 (+1 与上一季度对比) | 23 (+4 与上一季度对比) | +134K |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| SCHRODER INVESTMENT MANAGEMENT GROUP | $15823961 | 1477494 | 34.65% | 股份 |
| Allianz Asset Management GmbH | $7257739 | 674511 | 15.89% | 股份 |
| STATE STREET CORP | $3374454 | 313611 | 7.39% | 股份 |
| AIA Group Ltd | $3133624 | 291229 | 6.86% | 股份 |
| M&G PLC | $2670701 | 242791 | 5.85% | 股份 |
| Amundi | $2199183 | 204385 | 4.82% | 股份 |
| JANE STREET GROUP, LLC | $2092519 | 194472 | 4.58% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $1400952 | 130200 | 3.07% | 股份 |
| BNP PARIBAS FINANCIAL MARKETS | $1123613 | 104425 | 2.46% | 股份 |
| XY Capital Ltd | $1120439 | 104130 | 2.45% | 股份 |
| Crossmark Global Holdings, Inc. | $913685 | 84915 | 2.00% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $680548 | 63248 | 1.49% | 股份 |
| UBS Group AG | $475409 | 44183 | 1.04% | 股份 |
| Vanguard Personalized Indexing Management, LLC | $458365 | 42599 | 1.00% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $419285 | 38967 | 0.92% | 股份 |
| CITADEL ADVISORS LLC | $409536 | 38061 | 0.90% | 股份 |
| Vident Advisory, LLC | $286044 | 26584 | 0.63% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $284279 | 26420 | 0.62% | 股份 |
| StoneX Group Inc. | $213563 | 18262 | 0.47% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $195498 | 18169 | 0.43% | 股份 |
| AMERIPRISE FINANCIAL INC | $169384 | 15742 | 0.37% | 股份 |
| Summit Trail Advisors, LLC | $140848 | 13090 | 0.31% | 股份 |
| BANK OF AMERICA CORP /DE/ | $134382 | 12489 | 0.29% | 股份 |
| XTX Topco Ltd | $133521 | 12409 | 0.29% | 股份 |
| Mariner, LLC | $114659 | 10656 | 0.25% | 股份 |
| MORGAN STANLEY | $91944 | 8545 | 0.20% | 股份 |
| Blue Trust, Inc. | $82938 | 7708 | 0.18% | 股份 |
| ROYAL BANK OF CANADA | $58000 | 5428 | 0.13% | 股份 |
| Russell Investments Group, Ltd. | $51633 | 4821 | 0.11% | 股份 |
| RHUMBLINE ADVISERS | $41755 | 3881 | 0.09% | 股份 |
| FMR LLC | $32097 | 2983 | 0.07% | 股份 |
| Rockefeller Capital Management L.P. | $11632 | 1081 | 0.03% | 股份 |
| Bell Investment Advisors, Inc | $10922 | 1015 | 0.02% | 股份 |
| ASSETMARK, INC | $8737 | 812 | 0.02% | 股份 |
| BlackRock, Inc. | $7625 | 709 | 0.02% | 股份 |
| JPMORGAN CHASE & CO | $6405 | 598 | 0.01% | 股份 |
| Silver Grove Financial Group, Inc. | $6273 | 583 | 0.01% | 股份 |
| US BANCORP \DE\ | $5950 | 553 | 0.01% | 股份 |
| Arax Advisory Partners | $4304 | 400 | 0.01% | 股份 |
| North Star Investment Management Corp. | $4078 | 379 | 0.01% | 股份 |
| SIMPLEX TRADING, LLC | $3271 | 304 | 0.01% | 股份 |
| FIDUCIARY FINANCIAL ADVISORS | $3110 | 291 | 0.01% | 股份 |
| OSAIC HOLDINGS, INC. | $2485 | 231 | 0.01% | 股份 |
| CITIGROUP INC | $2055 | 191 | 0.00% | 股份 |
| Physician Wealth Advisors, Inc. | $1550 | 144 | 0.00% | 股份 |
| Cornerstone Financial Management LLC | $1442 | 134 | 0.00% | 股份 |
| Pinnacle Wealth Planning Services, Inc. | $1334 | 124 | 0.00% | 股份 |
| EverSource Wealth Advisors, LLC | $990 | 92 | 0.00% | 股份 |
| ACADIAN ASSET MANAGEMENT LLC | $696 | 65166 | 0.00% | 股份 |
| Larson Financial Group LLC | $387 | 36 | 0.00% | 股份 |
激进投资者及 5%+ 股东 4 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| HUTCHMED Group Investment Limited (formerly known as “Hutchison China MediTech Investment Limited”), HUTCHMED (China) Limited | 2022年2月7日 | · | 初始申报 | · | SEC |
| Hutchison China MediTech Investment Limited, HUTCHMED (China) Limited | 2021年8月16日 | · | 初始申报 | 被动投资 | SEC |
| General Atlantic Singapore HCM Pte. Ltd., General Atlantic Singapore Fund Pte. Ltd., General Atlantic Singapore Interholdco Ltd., General Atlantic Partners (Bermuda) IV, L.P., General Atlantic Partners (Bermuda) EU, L.P., General Atlantic Partners (Lux) SCSp, L.P., General Atlantic GenPar (Lux) SCSp, L.P., General Atlantic (Lux) S.à r.l., General Atlantic GenPar (Bermuda), L.P., GAP (Bermuda) Limited, General Atlantic LLC, GAP Coinvestments III, LLC, GAP Coinvestments IV, LLC, GAP Coinvestments V, LLC, GAP Coinvestments CDA, L.P. ×2 申报 | 2021年7月1日 | · | 初始申报 | · | SEC |
| Hutchison Healthcare Holdings Limited, Hutchison Whampoa (China) Limited, CK Hutchison Global Investments Limited, CK Hutchison Holdings Limited ×8 申报 | 2021年6月30日 | · | 初始申报 | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 4 位内幕人士 · 4 位高管 · 2 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Chig Fung Cheng | Acting CEO and CFO | 2026年5月20日 J | · | 0 | 0 | $0 |
| Wei-Guo Su | CEO and CSO | 2026年5月20日 J | · | 0 | 0 | $0 |
| Lorenso Chiu | Deputy Chief Financial Officer | 2026年5月20日 J | · | 0 | 0 | $0 |
| Charles George Rupert Nixon | Group General Counsel | 2026年5月20日 J | · | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 3 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
HCM 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 28 位分析师
买入
中位数目标
$19.50
+37.3%
10 35.7%
强烈买入
13 46.4%
买入
5 17.9%
持有
0 0.0%
卖出
0 0.0%
强烈卖出
12个月价格目标
14 位分析师 · 2026-10-02平均目标 $22.01 +55.0%
现在
当前价格 $14.20
最低$13.60
平均值$22.01
最高$40.40
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| HCM | $11.63B | 25.6 | · | 83.3% | 45.7% | · |
| RGC | $8.43B | -23.7 | · | · | -54.8% | · |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 20-F 于 三月 5, 2026 申报